New Horizon Health (HKSE:06606) EPS Growth Rate (Future 3Y To 5Y Estimate) : N/A (As of Jun. 07, 2024)

View and export this data going back to 2021. Start your Free Trial

What is New Horizon Health EPS Growth Rate (Future 3Y To 5Y Estimate)?

EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, New Horizon Health's EPS Growth Rate (Future 3Y To 5Y Estimate) is N/A.

Competitive Comparison of New Horizon Health's EPS Growth Rate (Future 3Y To 5Y Estimate)

For the Medical Devices subindustry, New Horizon Health's EPS Growth Rate (Future 3Y To 5Y Estimate), along with its competitors' market caps and EPS Growth Rate (Future 3Y To 5Y Estimate) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

New Horizon Health's EPS Growth Rate (Future 3Y To 5Y Estimate) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, New Horizon Health's EPS Growth Rate (Future 3Y To 5Y Estimate) distribution charts can be found below:

* The bar in red indicates where New Horizon Health's EPS Growth Rate (Future 3Y To 5Y Estimate) falls into.

New Horizon Health (HKSE:06606) EPS Growth Rate (Future 3Y To 5Y Estimate) Explanation

EPS Growth Rate (Future 3Y To 5Y Estimate) s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

New Horizon Health EPS Growth Rate (Future 3Y To 5Y Estimate) Related Terms

Thank you for viewing the detailed overview of New Horizon Health's EPS Growth Rate (Future 3Y To 5Y Estimate) provided by GuruFocus.com. Please click on the following links to see related term pages.

New Horizon Health (HKSE:06606) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » New Horizon Health Ltd (HKSE:06606) » Definitions » EPS Growth Rate (Future 3Y To 5Y Estimate)

Comparable Companies

Traded in Other Exchanges

6YZ:Germany

Address

400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052

Website

https://ir.newhorizonbio.com

New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.

Executives

Invesco Advisers, Inc.	2102 Investment manager
Chen Yiyou	2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited	2301 Trustee
Bancasa Holding Limited	2201 Interest of corporation controlled by you
Mst Development Limited	2101 Beneficial owner
Yao Naxin	2305 Beneficiary of a trust
Janus Henderson Group Plc	2102 Investment manager
Jpmorgan Chase & Co.	2106 Person having a security interest in shares
Invesco Developing Markets Fund	2106 Person having a security interest in shares
Zhu Yeqing	2101 Beneficial owner
Qiming Venture Partners V, L.p.
Qiming Gp V, L.p.
Qiming Corporate Gp V, Ltd.
Bei Jing Jun Qi Jia Rui Qi Ye Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Jun Lian Zi Ben Guan Li Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you

New Horizon Health (HKSE:06606) Headlines

No Headlines